Implanet S.A. (EPA:ALIMP)

France flag France · Delayed Price · Currency is EUR
0.3160
-0.0040 (-1.25%)
Sep 4, 2025, 1:44 PM CET
-1.25%
Market Cap40.19M
Revenue (ttm)9.41M
Net Income (ttm)-4.37M
Shares Out125.60M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume642,182
Average Volume875,064
Open0.3330
Previous Close0.3200
Day's Range0.3040 - 0.3410
52-Week Range0.0800 - 0.3600
Beta0.94
RSI85.43
Earnings DateSep 16, 2025

About Implanet

Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martill... [Read more]

Sector Healthcare
Founded 2006
Employees 46
Stock Exchange Euronext Paris
Ticker Symbol ALIMP
Full Company Profile

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.

Financial Statements

News

There is no news available yet.